Tag: sle
Cannabidiol is a non-psychotropic component of cannabis sativa. Known to induce an immunomodulatory effect, cannabidiol’s therapeutic properties have been explored in a number of autoimmune diseases.
11.03.2019
 
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires
13.09.2018
 
Recently, many scientists have focused on the importance of the commensal bacteria in the pathogenesis of several diseases, including autoimmune diseases. The aim of this review is to describe the main alterations of the microbiome that occur into the autoimmune diseases (1).
01.07.2018
 
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
01.07.2018
 
Molecular mimicry between humans and the microbiota is more common than appreciated. As presented by Martin Kriegel and colleagues (Greiling et al., 2018), this mimicry may mislead the immune system and trigger a friendly fire on our own tissues, as in the case of microbial-Ro60 and the autoimmune disease lupus.
01.07.2018
 
Antinuclear antibodies (ANA) are important biomarkers for systemic lupus erythematosus (SLE) and represent a criterion for patient classification. While ANAs are not specific for SLE, patients with SLE are thought to be almost invariably positive.
30.04.2018
 
Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction
22.04.2018
 
Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn’s disease and ulcerative colitis?
12.04.2018
 
Vitamin D may be considered as a pro-hormone which is obtained from 2 distinct sources; to a lesser extent diet, but principally by synthesis in the epidermal layer of the skin after UV exposure.
21.03.2018
 
Women with systemic lupus erythematosus and/or antiphospholipid antibodies are at increased risk for adverse pregnancy outcomes, including preeclampsia, fetal and neonatal death and fetal growth restriction.
19.02.2018
 
1